BNET Industries

ImClone Systems Inc.

(IMCL) is in the Pharma Industry

Last Fiscal Year Sales:$590.8M
  • Public
  • US
Dow Jones Description

We are a biopharmaceutical company whose mission is to advance oncology care by developing and commercializing a portfolio of targeted treatments designed to address the medical needs of patients with cancer. We focus on what we believe are two promising strategies for treating cancer: growth factor blockers and angiogenesis inhibitors. We were incorporated under the laws of the State of Delaware on April 26, 1984. Our corporate headquarters and research facility are located at 180 Varick Street, New York, New York 10014 and our telephone number is (212) 645-1405. We make available free of charge on our Internet website (http://www.imclone.com) our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to these reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act as soon as reasonably practicable after we electronically file such material with, or furnish it to, the Securities and Exchange Commission. In addition, our Internet website includes other items related to corporate governance matters, including among other things, our corporate governance guidelines, charters of the various committees of the Board of Directors, and our corporate compliance program (including our Code of Business Conduct and Ethics). ...

Chairman and Chief Executive Officer
James M. Cornelius
Number of Employees 1,128
Contact Information

180 Varick Street

New York, New York 10014

imclone.com

212.645.1405

NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414

Recent Events

  • Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference

    11/22/09 - Merger / Acquisition - View Story

  • Reuters Summit-Lilly CEO optimistic despite patent cliff

    11/09/09 - Merger / Acquisition - View Story

  • Eli Lilly Cuts 5500 Jobs

    9/17/09 - Merger / Acquisition - View Story

  • Three Recent Biotech Activist Wins by Carl Icahn

    8/31/09 - Board Member - Entering - View Story

  • Bristol-Myers Buoys Biologics in Medarex Buy

    7/23/09 - Merger / Acquisition - View Story

  • East River Science Park Has Its First Tenant

    7/21/09 - Sites Leased - View Story

News & Analysis

financial and imclone systems inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
John H. Johnson Chief Executive Officer
Samuel D. Waksal President
Eric K. Rowinsky Chief Medical Officer
Kenneth J. Zuerblis Senior Vice President & CFO
Ana I. Stancic Senior Vice President, Finance
Daniel J. O'Connor Senior Vice President, General Counsel & Secretary
Kenneth William Powell Andrew Senior Vice President, General Counsel
Larry Witte Senior Vice President, Research
Michael Bailey Senior Vice President, Commercial Operations
Peter Bohlen Senior Vice President, Res
Richard Crowley Senior Vice President, Biopharmaceutical Operations
Ronald A. Martell Senior Vice President, Commercial Operations
Andrea F. Rabney Vice President, Corp Communications
Charles Dunne Vice President, MIS & Facilities
Daniel Hicklin Vice President, Experimental Therapeutics
David M. Pitts Assistant Vice President, Corp Communications
David Schloss Vice President, Human Resources
Douglas E. Swan Vice President, Field Operations
Gary Paulter Vice President, Engineering & Facilities
Jeff Skulsky Vice President
Joan Connolly Associate Vice President, Strategy & Operations
John B. Landes Vice President, Business Development
Joseph Depinto Vice President, Commercial Operations
Lisa M. Cammy Vice President, HR
Marc Labelle Vice President
Margaret Dalesandro Vice President, Project Management
Margery B. Fischbein Vice President
Nikhil Mehta Vice President, CMC Regulatory Affairs
Paul A. Goldstein Vice President, Finance Operations
Peter R. Borzilleri Vice President, Internal Audit
Thomas C. Gallagher Vice President, Intellectual Property
Vivienne E. Arasi Vice President
Bernhard Ehmer Senior Vice President & Managing Director, Int'L Operations
Harlan W. Waksal Founder
Jason E. Farber Director, Corp Communications
Jan Sat

Board of Directors

Name (plus bio) Position
James M. Cornelius Chairman and Chief Executive Officer
Jules Haimovitz Chairman
Robert F Goldhammer Chairman of The Board of Directors
Alexander J. Denner Board of Directors
Andrew R.J. Bonfield Board of Directors
Charles Woler Board of Directors
David Sidransky Vice Chairman
John E. Celentano Board of Directors
Peter S. Liebert Board of Directors
Richard Mulligan Board of Directors
Thomas F. Deuel Board of Directors
Vincent T. Devita Jr. Board of Directors

Organization Position Status
ImClone Systems Incorporated Chairman and Chief Executive Officer Current

Organization Position Status
ImClone Systems Incorporated Chief Executive Officer Current

Organization Position Status
ImClone Systems Incorporated President Current

Eric K. Rowinsky, M.D. Dr. Rowinsky has served as a director since February 2008. Dr. Rowinsky currently is chief medical officer, a position he has held since February 2005, and executive vice president, a position he has held since December 2007, of ImClone Systems Incorporated, a wholly-owned subsidiary of Eli Lilly and Company. Dr. Rowinsky held the position of director of the Institute of Drug Development ( IDD ) at the Cancer Therapy and Research Center from 2002 to 2004 and was the director of clinical research at the IDD from 1996 to 2002. In addition, he held the SBC Endowed Chair for Early Drug Development at the IDD. From 1996 to 2006, Dr Rowinsky was also a clinical professor of medicine (division of medical oncology) at the University of Texas Health Science Center, San Antonio, Texas. Dr. Rowinsky also served as an associate professor of oncology at Johns Hopkins University from 1988 until 1996. He served on the Board of Scientific Counselors of the National Cancer Institute from 2004 to 2007. Dr. Rowinsky received a B.A. degree from New York University and an M.D. degree from the Vanderbilt University School of Medicine. Following his residency in internal medicine, he completed fellowship training in medical oncology at the Johns Hopkins University School of Medicine. There are no family relationships among any of the Company s directors or executive officers.

Organization Position Status
ImClone Systems Incorporated Chief Medical Officer Current
Adventrx Pharmaceuticals Inc Director Current
Supratek Pharma Inc Board of Directors Current
ImClone Systems Incorporated Executive Vice President of Clinical Development and Regulatory Former
Institute for Drug Development Director of Clinical Research Former
University of Texas Health Science Center at San Antonio Clinical Professor of Medicine Former
The Johns Hopkins University Associate Prof of Oncology Former
Johns Hopkins University School of Medicine Associate Professor of Oncology Former
Vanderbilt University School of Medicine M.D. Former
New York University B.A. Degree Former

Mr. Zuerblis owned no shares of the Company's stock at June 30, 2008, nor did he have any options exercisable prior to August 29, 2008.

Organization Position Status
ImClone Systems Incorporated Senior Vice President & CFO Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Finance Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, General Counsel & Secretary Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, General Counsel Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Research Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Commercial Operations Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Res Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Biopharmaceutical Operations Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President, Commercial Operations Current

Organization Position Status
ImClone Systems Incorporated Vice President, Corp Communications Current

Organization Position Status
ImClone Systems Incorporated Vice President, MIS & Facilities Current

Organization Position Status
ImClone Systems Incorporated Vice President, Experimental Therapeutics Current

Organization Position Status
ImClone Systems Incorporated Assistant Vice President, Corp Communications Current

Organization Position Status
ImClone Systems Incorporated Vice President, Human Resources Current

Organization Position Status
ImClone Systems Incorporated Vice President, Field Operations Current

Organization Position Status
ImClone Systems Incorporated Vice President, Engineering & Facilities Current

Organization Position Status
ImClone Systems Incorporated Vice President Current

Organization Position Status
ImClone Systems Incorporated Associate Vice President, Strategy & Operations Current

Organization Position Status
ImClone Systems Incorporated Vice President, Business Development Current

Organization Position Status
ImClone Systems Incorporated Vice President, Commercial Operations Current

Organization Position Status
ImClone Systems Incorporated Vice President, HR Current

Organization Position Status
ImClone Systems Incorporated Vice President Current

Organization Position Status
ImClone Systems Incorporated Vice President, Project Management Current

Organization Position Status
ImClone Systems Incorporated Vice President Current

Organization Position Status
ImClone Systems Incorporated Vice President, CMC Regulatory Affairs Current

Organization Position Status
ImClone Systems Incorporated Vice President, Finance Operations Current

Organization Position Status
ImClone Systems Incorporated Vice President, Internal Audit Current

Organization Position Status
ImClone Systems Incorporated Vice President, Intellectual Property Current

Organization Position Status
ImClone Systems Incorporated Vice President Current

Organization Position Status
ImClone Systems Incorporated Senior Vice President & Managing Director, Int'L Operations Current

Organization Position Status
ImClone Systems Incorporated Founder Current
Senesco Technologies Inc. Chairman Current
Oberlin College Board of Directors Current
Montclair Art Museum Board of Directors Current
ImClone Systems Incorporated Director Former
Tufts University School of Medicine M.D. Former
Oberlin College Bachelor of Arts In Biology Former

Organization Position Status
ImClone Systems Incorporated Director, Corp Communications Current
ImClone Systems Incorporated Director, Corp Communications Former
Shell Oil Company geophysicist Former

Organization Position Status
ImClone Systems Incorporated Current

Organization Position Status
Dick Clark Productions, Inc. Managing Director Current
The Brooklyn College Foundation, Inc Trustee Current
ImClone Systems Incorporated Chairman Current
Blockbuster, Inc. Board of Directors Current
Dick Clark Productions, Inc. Vice Chairman Current
InfoSpace, Inc. Board of Directors Current
King World Productions, Inc. President and Chief Operating Officer Former
Brooklyn College M.A. degree in Mathematics Former

Organization Position Status
Broadsword Partners, LLC Co-Founder Current
Community Connect, Inc. Chairman Current
ImClone Systems Incorporated Chairman of The Board of Directors Current
Broadsword Partners, LLC Board of Directors Current
The Boston Stock Exchange Inc. Chairman Former
Kidder, Peabody & Co. Vice Chairman of the Board of Directors Former
Boston University Former

In late January 2009, Dr. Denner was interviewed by Messrs. LeBuhn, Micati and Salisbury, and Professor Mulligan was interviewed by Drs. Ando and Geltosky and, at their invitation, Dr. Ivan Horak, the Company s Executive Vice President, Research and Development and Chief Scientific Officer. At a meeting of the Governance and Nominating Committee held on January 28, 2009, the Committee determined to recommend to the Board the nominations of Dr. Denner and Professor Mulligan for election as Class I Directors at the Annual Meeting. At a meeting of the Board held later that day, the Board determined to accept the recommendation of the Governance and Nominating Committee and nominated Dr. Denner and Professor Mulligan for election as Class I Directors at the Annual Meeting. At the request of the Icahn Group, the Board committed to the Icahn Group that if, for any reason, the Board subsequently determined not to nominate both Dr. Denner and Professor Mulligan, or to nominate any persons in addition to Dr. Denner and Professor Mulligan, for election as Class I Directors at the Annual Meeting, the Company would give the Icahn Group prompt written notice thereof and the Company would take all necessary action to permit the Icahn Group to nominate persons named in a notice of nomination for election to the Board which the Icahn Group would deliver to the Company on or before the close of business on the tenth day following the date on which the Icahn Group received such written notice from the Company.

Organization Position Status
Enzon Pharmaceuticals, Inc. Managing Director of Entities Current
Enzon Pharmaceuticals, Inc. Director Current
Amylin Pharmaceuticals, Inc. Board of Directors Current
Biogen Idec, Inc. Director Current
Camargoblog.Com Director Current
Hypermed, Inc. Director Current
Adventrx Pharmaceuticals Inc Board of Directors Current
ImClone Systems Incorporated Chairman Former
ImClone Systems Incorporated Board of Directors Former
Yale University M.Phil. Former

Organization Position Status
Bristol-Myers Squibb Company Executive Vice President & Chief Financial Officer Current
Bristol-Myers Squibb Company Senior Vice President Current
Boc Limited Non-Executive Director Current
ImClone Systems Incorporated Board of Directors Current
Bristol-Myers Squibb Company Board of Directors Former

Organization Position Status
Duke Street Capital Operating Partner Current
ImClone Systems Incorporated Board of Directors Current
GlaxoSmithKline Plc Former

Organization Position Status
ImClone Systems Incorporated Vice Chairman Current
ImClone Systems Incorporated Board of Directors Current

Organization Position Status
ImClone Systems Incorporated Board of Directors Current

Organization Position Status
ImClone Systems Incorporated Board of Directors Current
Cadus Corp Director Current

Organization Position Status
ImClone Systems Incorporated Board of Directors Current

Organization Position Status
ImClone Systems Incorporated Board of Directors Current

Organization Position Status
ImClone Systems Incorporated Board of Directors Current

Executive News

  • Three Recent Biotech Activist Wins by Carl Icahn

    Seeking Alpha - 8/31/09 - View Story

advertisement
IndustryTop Rated
advertisement